Skip to main content
. 2022 Mar 4;55(10):1330–1341. doi: 10.1111/apt.16820

TABLE 2.

Risk of first ADM use in the first year and 10 years following diagnosis amongst individuals with IBD compared with the control cohort

Outcome First year Ten years
Unadjusted HR (95% CI; P value) Adjusted* HR (95% CI; P value) Unadjusted HR (95% CI; P value) Adjusted* HR (95% CI; P value)
Cohort
Matched controls 1 (−) 1 (−) 1 (−) 1 (−)
IBD 1.49 (1.34‐1.64; 0.000) 1.34 (1.21‐1.49; 0.000) 1.20 (1.13‐1.27; 0.000) 1.11 (1.04‐1.18; 0.001)
Sex
Male 1 (−) 1 (−) 1 (−) 1 (−)
Female 1.46 (1.32‐1.61; 0.000) 1.43 (1.29‐1.58; 0.000) 1.44 (1.37‐1.52; 0.000) 1.45 (1.38‐1.53; 0.000)
Age at diagnosis (years)
<18 0.14 (0.09‐0.24; 0.000) 0.24 (0.15‐0.41; 0.000) 0.56 (0.49‐0.65; 0.000) 0.67 (0.57‐0.78; 0.000)
18‐25 1.29 (1.08‐1.53; 0.007) 1.42 (1.19‐1.70; 0.000) 1.57 (1.44‐1.72; 0.000) 1.67 (1.52‐1.84; 0.000)
25‐40 1.22 (1.08‐1.39; 0.002) 1.25 (1.10‐1.42; 0.000) 1.29 (1.20‐1.38; 0.000) 1.29 (1.21‐1.39; 0.000)
40‐60 1 (−) 1 (−) 1 (−) 1 (−)
≥60 0.90 (0.79‐1.02; 0.103) 0.91 (0.80‐1.04; 0.162) 0.95 (0.89‐1.02; 0.192) 0.97 (0.91‐1.04; 0.437)
Social deprivation
IMD 1‐3 1 (−) 1 (−) 1 (−) 1 (−)
IMD 4‐5 1.18 (1.02‐1.35; 0.018) 1.09 (0.95‐1.25; 0.214) 1.19 (1.10‐1.28; 0.000) 1.12 (1.04‐1.21; 0002)
Unknown 1.04 (0.93‐1.68; 0.442) 1.02 (0.91‐1.14; 0.735) 1.06 (0.99‐1.12; 0.067) 1.00 (0.95‐1.07; 0.815)
Era of IBD diagnosis
Era 1: 2004‐2007 1 (−) 1 (−) 1 (−) 1 (−)
Era 2: 2008‐2011 1.13 (1.00‐1.28; 0.045) 1.02 (0.90‐1.15; 0.772) 1.30 (1.22‐1.38; 0.000) 1.27 (1.19‐1.35; 0.000)
Era 3: 2012‐2015 1.56 (1.39‐1.77; 0.000) 1.35 (1.19‐1.53; 0.000) 1.82 (1.69‐1.97; 0.000) 1.76 (1.63‐1.91; 0.000)
Smoking status, n (%)
Never 1 (−) 1 (−) 1 (−) 1 (−)
Smoker 2.02 (1.77‐2.30; 0.000) 1.94 (1.70‐2.21; 0.000) 1.74 (1.62‐1.89; 0.000) 1.71 (1.58‐1.84; 0.000)
Ex‐smoker 1.25 (1.10‐1.42; 0.001) 1.26 (1.10‐1.45; 0.001) 1.17 (1.08‐1.26; 0.000) 1.24 (1.15‐1.34; 0.000)
Missing 0.46 (0.39‐0.54; 0.000) 0.53 (0.45‐0.63; 0.000) 0.89 (0.84‐0.96; 0.003) 0.99 (0.92‐1.07; 0.797)
Corticosteroid use
No 1 (−) 1 (−) 1 (−) 1 (−)
Yes 0.83 (0.57‐1.21; 0.328) 1.11 (0.76‐1.64; 0.585) 0.78 (0.63‐0.94; 0.010) 0.89 (0.73‐1.10; 0.260)

All covariates in the table were included within the adjusted analysis. Abbreviations: ADM (Antidepressant medication); HR (Hazard Ratio); CI (Confidence Interval) * IBD (Inflammatory Bowel Disease) *IMD ‐ Index of Multiple Deprivation; IMD 1 represents the least deprived and IMD 5 the most deprived. IMD ‐ Data are available only for individual’s resident in England.

Bold values indicate statistical significance.